Las Vegas, NV -- (SBWIRE) -- 10/07/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO), Celsion Corporation (NASDAQ:CLSN), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), The First Marblehead Corporation (NYSE:FMD).
JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) managed to keep its fall at -0.83% on traded volume of 2.17 million shares. The stock settled at $3.05 after floating in a range of $10.54 to $11.10. After recent close, it has reached market capitalization of $86.72 million. Its 52-week range has been $2.91 to $11.40. JA Solar Holdings Co., Ltd., through its subsidiaries, engages in the design, development, production, marketing, and sale of solar power products based on crystalline silicon technologies.
Will JASO Get Buyers Even After The Recent Rally? Find Out Here
Celsion Corporation (NASDAQ:CLSN) traded up on a volume of 1.98 million, higher than its standard daily volume. Shares have gained 1.60% to $1.27. Over the last twelve months the stock has lost -78.62% and faced a worst price of $1.24. Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of targeted chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology.
Will CLSN Continue To Move Higher? Find Out Here
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) settled 3.43% higher at $2.11 on traded volume of 1.90 million shares during the last trading day, while its average trading volume remained 471.580 shares. The stock has its 12-month low at $2.03 and 52-week high price was $10.27. It traded in a range of $2.04 to $2.23 during the last trading day. AVEO Pharmaceuticals, Inc., doing business as AVEO Oncology, operates as a cancer therapeutics company. The company engages in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform.
Will AVEO Continue To Move Higher? Find Out Here
The First Marblehead Corporation (NYSE:FMD) saw its price fall on traded volume as 1.90 million shares changed hands when compared with its average daily volume of 1.03 million shares. The stock was down -0.94% to $0.799. It has fallen over the last 12 months, dropping -23.9% and marked new low $0.61. The First Marblehead Corporation, a specialty finance company, together with its subsidiaries, provides loan programs on behalf of its lender clients for K-12, undergraduate, and graduate students, as well as for college graduates seeking to refinance private education loan obligations.
Will FMD Get Buyers Even After The Recent Rally? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)